Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
A therapeutic drug development company developing treatments for multiply resistant bacteria.Funding
Funding rounds
Cap Table
Current and past shareholders
Investor | Contacts | Round | |
---|---|---|---|
Cambridge Capital Group |
+44 (1223) 472-746 |
N/A | |
ET Capital Ltd Venture capital firm |
+44 (1223) 236-632 |
N/A |